Local tissue distribution and cellular fate of vascular endothelial growth factor (VEGF) following intramuscular injection

A L Daugherty, R J Mrsny

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Vascular endothelial growth factor (VEGF) is an extracellular matrix (ECM)-binding growth factor capable of driving neovascularization. VEGF can potentially be applied clinically via intramuscular (IM) injection to correct local ischemia associated with peripheral artery disease (PAD). As interactions with ECM elements and cognate receptors at the site of an IM injection define the local biology of VEGF and previous studies have only focused on systemic distribution measurements, we have established a method to monitor the local VEGF distribution and fate. Fluorescent-labeled VEGF was prepared that bound to ECM and activated a cognate receptor similarly to VEGF. Beginning by 2 h and becoming complete by 12 h following injection, fluorescence microscopy demonstrated the transition of labeled VEGF from an initial extensive interaction with ECM components to a focused labeling of vascular endothelial cells. Biochemical characterization verified the association of VEGF with ECM components and modification of endothelial cell function associated with vascular permeability changes known to accompany VEGF actions. Our data provide information concerning temporal and spatial VEGF fate and actions at the site of an IM injection that can help guide decisions regarding the identification of acceptable formulation strategies.
Original languageEnglish
Pages (from-to)27-35
Number of pages9
JournalJournal of Drug Targeting
Volume18
Issue number1
DOIs
Publication statusPublished - Jan 2010

Fingerprint

Intramuscular Injections
Tissue Distribution
Vascular Endothelial Growth Factor A
Extracellular Matrix
Endothelial Cells
Peripheral Arterial Disease
Capillary Permeability
Fluorescence Microscopy
Intercellular Signaling Peptides and Proteins
Ischemia
Injections

Cite this

Local tissue distribution and cellular fate of vascular endothelial growth factor (VEGF) following intramuscular injection. / Daugherty, A L; Mrsny, R J.

In: Journal of Drug Targeting, Vol. 18, No. 1, 01.2010, p. 27-35.

Research output: Contribution to journalArticle

@article{d371a9d4729d407eb2818202c8e9c4b9,
title = "Local tissue distribution and cellular fate of vascular endothelial growth factor (VEGF) following intramuscular injection",
abstract = "Vascular endothelial growth factor (VEGF) is an extracellular matrix (ECM)-binding growth factor capable of driving neovascularization. VEGF can potentially be applied clinically via intramuscular (IM) injection to correct local ischemia associated with peripheral artery disease (PAD). As interactions with ECM elements and cognate receptors at the site of an IM injection define the local biology of VEGF and previous studies have only focused on systemic distribution measurements, we have established a method to monitor the local VEGF distribution and fate. Fluorescent-labeled VEGF was prepared that bound to ECM and activated a cognate receptor similarly to VEGF. Beginning by 2 h and becoming complete by 12 h following injection, fluorescence microscopy demonstrated the transition of labeled VEGF from an initial extensive interaction with ECM components to a focused labeling of vascular endothelial cells. Biochemical characterization verified the association of VEGF with ECM components and modification of endothelial cell function associated with vascular permeability changes known to accompany VEGF actions. Our data provide information concerning temporal and spatial VEGF fate and actions at the site of an IM injection that can help guide decisions regarding the identification of acceptable formulation strategies.",
author = "Daugherty, {A L} and Mrsny, {R J}",
year = "2010",
month = "1",
doi = "10.3109/10611860903134317",
language = "English",
volume = "18",
pages = "27--35",
journal = "Journal of Drug Targeting",
issn = "1061-186X",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Local tissue distribution and cellular fate of vascular endothelial growth factor (VEGF) following intramuscular injection

AU - Daugherty, A L

AU - Mrsny, R J

PY - 2010/1

Y1 - 2010/1

N2 - Vascular endothelial growth factor (VEGF) is an extracellular matrix (ECM)-binding growth factor capable of driving neovascularization. VEGF can potentially be applied clinically via intramuscular (IM) injection to correct local ischemia associated with peripheral artery disease (PAD). As interactions with ECM elements and cognate receptors at the site of an IM injection define the local biology of VEGF and previous studies have only focused on systemic distribution measurements, we have established a method to monitor the local VEGF distribution and fate. Fluorescent-labeled VEGF was prepared that bound to ECM and activated a cognate receptor similarly to VEGF. Beginning by 2 h and becoming complete by 12 h following injection, fluorescence microscopy demonstrated the transition of labeled VEGF from an initial extensive interaction with ECM components to a focused labeling of vascular endothelial cells. Biochemical characterization verified the association of VEGF with ECM components and modification of endothelial cell function associated with vascular permeability changes known to accompany VEGF actions. Our data provide information concerning temporal and spatial VEGF fate and actions at the site of an IM injection that can help guide decisions regarding the identification of acceptable formulation strategies.

AB - Vascular endothelial growth factor (VEGF) is an extracellular matrix (ECM)-binding growth factor capable of driving neovascularization. VEGF can potentially be applied clinically via intramuscular (IM) injection to correct local ischemia associated with peripheral artery disease (PAD). As interactions with ECM elements and cognate receptors at the site of an IM injection define the local biology of VEGF and previous studies have only focused on systemic distribution measurements, we have established a method to monitor the local VEGF distribution and fate. Fluorescent-labeled VEGF was prepared that bound to ECM and activated a cognate receptor similarly to VEGF. Beginning by 2 h and becoming complete by 12 h following injection, fluorescence microscopy demonstrated the transition of labeled VEGF from an initial extensive interaction with ECM components to a focused labeling of vascular endothelial cells. Biochemical characterization verified the association of VEGF with ECM components and modification of endothelial cell function associated with vascular permeability changes known to accompany VEGF actions. Our data provide information concerning temporal and spatial VEGF fate and actions at the site of an IM injection that can help guide decisions regarding the identification of acceptable formulation strategies.

UR - http://www.scopus.com/inward/record.url?scp=72749118786&partnerID=8YFLogxK

UR - http://dx.doi.org/10.3109/10611860903134317

U2 - 10.3109/10611860903134317

DO - 10.3109/10611860903134317

M3 - Article

VL - 18

SP - 27

EP - 35

JO - Journal of Drug Targeting

JF - Journal of Drug Targeting

SN - 1061-186X

IS - 1

ER -